Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0000950170-25-036694

Head of R&D, CSO gave up 8,504 shares (to pay taxes)

  • Head of R&D, CSO acquired 17,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Rodino-Klapac Louise · Head of R&D, CSO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-06 Exercise or conversion : show line 1 in the form +17,500 82,822 D
2025-03-07 Shares withheld for taxes : show line 2 in the form −514 $103.70 $53,302 82,308 D
2025-03-07 Shares withheld for taxes : show line 3 in the form −7,990 $103.70 $828,563 74,318 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-06 Exercise or conversion : show line 4 in the form Performance Stock Units −17,500 0 D
Loading xslF345X05/ownership.xml…